Skip to Content Facebook Feature Image

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

Business

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals
Business

Business

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

2025-11-26 14:44 Last Updated At:15:46

HONG KONG, Nov. 26, 2025 /PRNewswire/ -- In a groundbreaking new episode, CNN's long-running series Vital Signs delves into the cutting-edge science of hibernation, revealing how the secrets of the animal kingdom could unlock revolutionary advancements in human health, from fighting cancer and heart disease to facilitating space travel. This November, CNN's Chief Medical Correspondent, Dr. Sanjay Gupta, takes viewers on a global journey to meet the extraordinary individuals leading the charge in understanding hibernation in mammals and potentially inducing human torpor one day. 

CNN first visits the University of Utah, where Professor of Neurobiology Chris Gregg is exploring the genetic links between hibernation and cancer. Inspired by his own battle with stage 4 male breast cancer, Gregg, alongside researchers Alana Welm and K-T Varley at the Huntsman Cancer Institute, is investigating why cancer growth ceases in animals during hibernation. Their research meticulously studies dormant cancer cells, seeking to understand "why cancer cells go dormant, how they stay dormant, and what reactivates them," offering profound implications for cancer treatment.

The journey continues to Fauna Bio, a biotech company where researchers are studying the "Usain Bolts of hibernators" — the 13-lined ground squirrel. These remarkable creatures survive up to 25 "mini heart attacks or strokes" during their six-month hibernation yet repair all damage. Fauna Bio has developed their own AI platform to compare the genetic biobanks of hibernators and humans, identifying compounds and genes that could protect human heart cells. This research has already led to preclinical safety trials for a drug aimed at treating conditions like heart failure. Additionally, the team is developing a "RESPYRS Unit" for NASA, preparing to send squirrels into space to study hibernation in microgravity, aiming to understand its potential for long-duration human space travel.

Vital Signs then travels to the RIKEN Laboratory for Hibernation Biology in Kobe, Japan, to meet Dr. Genshiro Sunagawa. His team's pioneering work in 2020 demonstrated the ability to induce a torpor-like state in non-hibernating mice by activating specific "Q neurons" in the brain. Dr. Sunagawa envisions a future where humans could safely and efficiently hibernate, transforming emergency medicine by enabling safer patient transport, reducing the need for general anaesthesia during surgery, and vastly extending the viability of organs for transplant. He also explores the profound connection between hibernation and mental health, hypothesizing that conditions like Seasonal Affective Disorder may share an evolutionary origin with hibernation, a natural mechanism for survival.

Finally, the episode touches upon recent studies at the University of Pittsburgh in conjunction with NASA, which successfully induced a torpor-like state in human participants for up to 20 hours at a time using an FDA-approved sedative. These participants experienced reduced metabolic rates and could still perform complex tasks, hinting at the tangible near-future applications of this groundbreaking science.

From battling disease on Earth to exploring the cosmos, Vital Signs reveals how the profound lessons from hibernating animals are paving the way for a healthier, more adaptable human future.

Vital Signs trailers: https://bit.ly/4psV4mq 

Vital Signs images: https://bit.ly/4oW2gYe 

Vital Signs microsite: https://edition.cnn.com/health/vital-signs 

Airtimes for 30-minute special: 

Saturday, 29th November at 2:30pm and 7:30pm HKT

Sunday, 30th November at 2:30am and 12pm HKT

- Ends –

About CNN International  

CNN's portfolio of news and information services is available in seven different languages across all major TV, digital and mobile platforms, reaching more than 379 million households around the globe. CNN International is the number one international TV news channel according to all major media surveys across Europe, the Middle East and Africa, the Asia Pacific region, and Latin America and has a US presence that includes CNNgo. CNN Digital is a leading network for online news, mobile news and social media. CNN is at the forefront of digital innovation and continues to invest heavily in expanding its digital global footprint, with a suite of award-winning digital properties and a range of strategic content partnerships, commercialised through a strong data-driven understanding of audience behaviours. CNN has won multiple prestigious awards around the world for its journalism. Around 1,000 hours of long-form series, documentaries and specials are produced every year by CNNI's non-news programming division. CNN has 36 editorial offices and more than 1,100 affiliates worldwide through CNN Newsource. CNN International is a Warner Bros. Discovery company. 

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

PUNE, India, April 2, 2026 /PRNewswire/ -- EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company's comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.

"FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.

India's transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition."

— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility

Strong Business Momentum Across Segments

  • Electric Bus Leadership:
    Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi
  • SCV Breakout Year:
    Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption
  • Electric Trucks:
    New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification
  • Hydrogen Fuel Cell:
    Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses

Key Highlights:

Global Expansion:

  • Commenced electric bus deployments in Africa
  • Partnership with Kerchanshe Group for CKD assembly and distribution
  • Agreement with NBFI Capital for manufacturing in Australia

Manufacturing Scale-Up:

  • Two Pune facilities operational; Pithampur plant to be operational shortly
  • Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs

Retail Network:

  • Expanded dealership network; plans to add 120 dealerships in FY27

Order Book Visibility:

  • 6,000+ confirmed e-buses to be delivered over the next two years

About EKA Mobility

EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India's commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.

EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.

To know more about the company, kindly visit: https://ekamobility.com 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

EKA Mobility Achieves 5x Volume Growth

EKA Mobility Achieves 5x Volume Growth

Recommended Articles